Gilead Sciences Inc (NASDAQ:GILD)

74.83
Delayed Data
As of Sep 20
 +0.95 / +1.29%
Today’s Change
64.27
Today|||52-Week Range
89.54
+4.45%
Year-to-Date

Today’s Trading

Previous close73.88
Today’s open73.96
Day’s range73.84 - 74.96
Volume5,883,665
Average volume (3 months)6,511,374
Market cap$95.8B
Data as of 4:00pm ET, 09/20/2018

Growth & Valuation

Earnings growth (last year)-64.69%
Earnings growth (this year)-25.50%
Earnings growth (next 5 years)-1.30%
Revenue growth (last year)-13.79%
P/E ratio44.5
Price/Sales3.62
Price/Book4.73

Competitors

 Today’s
change
Today’s
% change
BIIBBiogen+2.33+0.69%
AMGNAmgen+1.90+0.94%
ILMNIllumina Inc+5.95+1.70%
TLRYTilray Inc-37.71-17.62%
Data as of 4:15pm ET, 09/20/2018

Financials

Next reporting dateOctober 30, 2018
EPS forecast (this quarter)$1.61
Annual revenue (last year)$26.1B
Annual profit (last year)$4.6B
Net profit margin17.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
CFO, Principal Accounting Officer &
Executive VP
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts